Reuters: IPOX® Associate Lukas Muehlbauer Comments on SpaceX IPO and Broader Listing Trends

Reuters reports that SpaceX’s expected mega IPO could become a landmark event for Wall Street, with the company’s anticipated listing set to draw strong investor attention because of its scale, Elon Musk’s following, and investor interest in AI infrastructure, space, and Starlink. However, the article notes that analysts and market participants do not view the offering as a reliable signal of a broad IPO market recovery.

IPOX® Research Associate Lukas Muehlbauer was quoted in the article, providing context on why SpaceX should not be treated as a normal test case for the IPO market. His commentary emphasized that investor demand remains concentrated in companies tied to strong market themes, including industrials, AI infrastructure, defense, energy, and parts of biotech.

“SpaceX is so large and extraordinarily valued that it doesn't lend itself as a normal test case for the IPO market.”

“The IPO market has reopened, but the appetite is still concentrated in companies that match strong thematics such as industrials, AI infrastructure, defense, energy and parts of biotech.”

Muehlbauer also discussed how the expected SpaceX listing may influence timing decisions for other issuers, noting that some companies may seek to complete offerings before SpaceX absorbs significant investor attention.

“The wider narrative has been that some companies have accelerated their IPO plans to get ahead of SpaceX, which is momentum that could continue as issuers try to go public before the listing absorbs a large share of investor attention next month.”

Read the full article by Manya Saini and Lucy Raitano on Reuters: Why SpaceX's mega IPO may not signal a broader rebound in listings